MVASI™ – The biosimilar option to Avastin®

Providing ophthalmic solutions to retinologists and ophthalmologists with confidence in quality has been an essential service we provide at Compound Preferred. With the vast experience from our Pharmacist in Charge and Quality Assurance and Regulatory Affairs Manager, we ensure our products are created in an FDA-approved ISO 8 room, and USP testing is conducted.

In an effort to provide even more cost-effective products, we are not only aliquoting Avastin but producing an Avastin biosimilar, MVASI. 

Play Video

Facts about MVASI

MVASI and Avastin have the same inactive ingredients

Various insurance formularies accept MVASI

MVASI is less expensive than Avastin

References

Contact Bretagne Pullens to learn more.

503B Outsourcing Facility Myths and Facts

503B outsourcing facilities provide in- office-use medications to the medical community. Regulated by the FDA and state entities, 503B facilities are fairly new to the

Procaine in the Neural Therapy World

Procaine is a compounded local anesthetic used as an alternative to Lidocaine and a viable companion for neural therapy and acupuncture. Neural therapy involves injecting